Arcadia Biosciences Inc reports results for the quarter ended September 30 - Earnings Summary

• Arcadia Biosciences Inc RKDA.OQ reported a quarterly adjusted loss of $1.18​​ per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of $-1.44. The mean expectation of two analysts for the quarter was for a loss of 81 cents per share. Wall Street expected results to range from -85 cents to -77 cents per share.

• Revenue fell 3.8% to $1.54 million from a year ago; analysts expected $1.40 million.

• Arcadia Biosciences Inc's reported EPS for the quarter was a loss of $1.18​.

• The company reported a quarterly loss of $1.61 million.

• Arcadia Biosciences Inc shares had risen by 55.3% this quarter and gained 35.5% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 13.8% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

• The average consensus recommendation for the food processing peer group is also "buy"

Wall Street's median 12-month price target for Arcadia Biosciences Inc is 9.00

This summary was machine generated from LSEG data November 13 at 12:08 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)